CD Genomics designed a pre-configured panel targeting 27.7 kb of genomic regions containing methylation biomarkers for early detection of eight major cancers: colorectal/esophageal/gastric/liver/lung/ovarian/pancreatic/prostate cancer. The solution enables non-invasive multi-cancer screening in clinical settings.
Comprehensive Cancer Marker Coverage
· Interrogates 12 methylation markers across all eight cancer types
Optimized Liquid Biopsy Performance
· Integrated with single-stranded DNA library preparation technology for sensitive detection of low-frequency variants in cell-free DNA (cfDNA)
| Enrichment Method: | Probe Hybridization Capture |
| Species: | Human |
| Variant Types: | 12 methylation markers |
| Target Size: | 27.7 Kb |
| Sample Type: | Tissue、FFPE、blood etc. |
| Method: | NGS |
| Sequencing Platform: | Illumina |
| Storage: | Store at -20 °C. |
1. Excellent Performance
Validation studies using four sample types demonstrated the following performance metrics for the CDCap™ Early Methylation Screening Panel at 8-10 ng DNA input.
Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.
Please fill out the form below: ×
